THE GREATEST GUIDE TO PMTA 0 11

In addition it addresses the FDA’s communications with the applicant, the retention of data that support the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant could transfer possession of an SE report back to a new applicant and electronic submission from the SE report and amendment